Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by FTI Consulting naming Colm Burke .
Filed returns
6
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2025 | FTI Consulting | Finance | Invitation to Mastercard Roundtable (Public policy or programme) | 28 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals virtual meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | FTI Consulting | Health | Jazz Pharmaceuticals held introductory meetings to discuss Jazz’s operations in Ireland and the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2022 | FTI Consulting | Health | Jazz Pharmaceuticals reached out to a number of DPO’s requesting an introductory meeting to discuss the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2021 | FTI Consulting | Health | FTI Consulting sent a copy of a press release, on behalf of Jazz Pharmaceuticals, regarding the public announcement of HSE’s reimbursement of Epidyolex (Public policy or programme) | 18 | On lobbying.ie |
| Jan–Apr 2021 | FTI Consulting | Health | GW Pharmaceuticals met with David Cullinane TD and Colm Burke TD, in the context of their membership of the Oireachtas Health Committee, to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 5 | 83.3% | |
| Finance | 1 | 16.7% |